Skip to content
Cultural Foundation
Author:
Regenerative Medical Technology Group
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
June 23, 2026
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
June 17, 2026
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
June 10, 2026
Dr. Erica Oberg’s New Book Healthy Hedonism Reframes Pleasure as Preventive Medicine to Help Navigate Stress, Midlife Change, and Modern Burnout
May 29, 2026
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
March 26, 2026